Abstract:Abstract Funding Acknowledgements Type of funding sources: None. Introduction Heart failure (HF) represents an important burden to the medical system attending to its high prevalence and high risk of hospital admissions by decompensations. Remote monitoring (RM) systems using invasive and non-invasive parameters were developed to anticipate clinical deterioration in patients with cardiac implantable electronic devices (CIEDs). Objective To characterize a cohort of patients with HF and CIEDs in an outermost region. We aimed to accessed data from monitoring device algorithms and to analyze the real impact in clinical decompensations, hospital admissions and all-cause mortality. Methods Retrospectively multicenter cohort study included 211 patients with HFrEF and CIEDs, between 2010 and 2020. This study population was divided into two specific groups: Group A including patients with RM data and Group B including patients who receive usual care at regular hospital consultations. RM technology applied used different parameters to access the risk of worsening HF and stablishing an alert threshold. Results Out of 211 patients enrolled, 75% were male and 44.8% were in NYHA functional class II at the time of device implantation. One-hundred and twenty (56.9%) received in-home monitoring system (89% Latitude® and 10.8% Carelink®), corresponding to the Group A. The remaining 91 patients (43.1%) were included in Group B. Forty-nine patients (40.8%) had transvenous implantable cardioverter defibrillator (ICD), 13 (10.8%) had a subcutaneous ICD, 54 (45%) a cardiac resynchronization therapy (CRT) defibrillator and 4 (3.3%) a CRT pacemaker. Group A patients did not have coronary artery disease (p 0.047) and were younger than patients in Group B (median age 66 years, IQR 55 – 73; median age 70 years, IQR 63 – 77). No other statistically differences in main comorbidities were detected between groups. The number of atrial fibrillation (AF) episodes and AF burden was higher in Group A during the follow-up (p 0.006) as well as non-sustained ventricular tachycardia episodes (p 0.016). However, no differences were accessed in emergency department (ED) admissions or heart failure hospitalizations (HFH) by decompensation for patients in group A who received alerts versus patients who not received (p 0.178 and p 0.748, respectively) nor between group A and B (p 0.921 and p 0.213, respectively). Patients in group A had a lower all-cause mortality rate (p < 0.001) and cardiovascular mortality (p 0.002), but no difference in life-threatening ventricular events occurred. Conclusion In our cohort of HF patients, remote monitoring allowed the premature detection and the correct quantification of arrhythmic events but did not reflect any difference in ED nor HFH by decompensation. Instead, RM system demonstrates ability to reduce global mortality when compared to conventional care. More data about the application of this system and the ideal tracking algorithms are necessary.

Effects of remote monitoring of cardiac implantable electronic devices after stroke or transient ischemic attack

[Experiences of Applying Home Monitoring for Cardiac Implantable Electronic Devices].

Remote monitoring of implantable cardioverter defibrillators: a systematic review and meta-analysis of randomised controlled trials

Assessing adherence to remote monitoring recommendations for cardiovascular implantable electronic devices: a retrospective analysis

Comparing the outcomes and costs of cardiac monitoring with implantable loop recorders and mobile cardiac outpatient telemetry following stroke using real-world evidence.

Abstract TMP48: Long-Term Cardiac Monitoring in Cryptogenic Stroke: The San Diego Experience

Telemonitoring heart failure in a remote region: data from cardiac implantable electronic devices

Detection of Ventricular Tachycardia by an Implantable Cardiac Monitor 8 Months Post-myocardial Infarction

Remote monitoring of implantable loop recorders reduces time to diagnosis in patients with unexplained syncope: a multicenter propensity score-matched study

Clinical application of remote monitoring in post-pacemaker implantation follow-up

Utilization of the remote monitoring of cardiac implantable electronic devices in a diverse demographic cohort: Insights from a single-center observation

Remote ischemic conditioning reduces adverse events in patients with acute ischemic stroke complicating acute myocardial infarction: a randomized controlled trial

NURSING COUNSELING FOR THE OPTIMIZATION OF THE REMOTE MANAGEMENT OF PATIENTS WITH ILR AFTER CRYPTOGENIC STROKE

Effect of implantable cardiac monitors on preventing stroke: A systematic review and meta-analysis of randomized clinical trials

Heart failure management guided by remote multiparameter monitoring: A meta-analysis

Predicting Malignant Ventricular Arrhythmias Using Real-Time Remote Monitoring

Early evaluation of atrial high rate episodes using remote monitoring in pacemaker patients: Results from the RAPID study

Impact of Remote Monitoring on Clinical Outcomes in Defibrillator Patients During the COVID-19 Pandemic: An Interrupted Time Series Analysis

Current status of reimbursement practices for remote monitoring of cardiac implantable electrical devices across Europe

Remote Monitoring of Cardiac Implantable Electronic Devices in Very Elderly Patients: Advantages and Specific Problems

Cost impact of the use of a universal cardiac implantable electronic devices remote monitoring solution: results of the Evidence RM study